Clinical trial
Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in…
NCT00086281 · Jazz Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00086281 |
|---|---|
| Title | Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients |
| Official title | Randomized, Placebo-Controlled Multicenter Trial of the Effects of Orally Administered Xyrem (Sodium Oxybate) and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients |
| Lead sponsor | Jazz Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obstructive Sleep Apnea Syndrome |
| Intervention type | Drug |
| Interventions | Xyrem (X), Zolpidem (Z), Modafinil (M), Placebo (P) |
| Enrollment | 60 |
| Start date | Nov 1, 2003 |
| Primary completion | Jun 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Jul 1, 2004 |
| Last update posted | Feb 24, 2012 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: